BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC

Table 3

The association between the BMP-4 expression and chemotherapy response status.

BMP-4 expression	Nonresponders		Responders		OR^†	95% CI^†		𝑃^†
Low	32	41.56%	24	66.67%	1.00
High	45	58.44%	12	33.33%	2.81	1.23	6.44	0.01

†Adjusted with age, sex, smoke status, histology, stage, and chemotherapy agents.